Journal profile · Pharmacology & Pharmacy
European Review for Medical and Pharmacological Sciences
ISSN 1128-3602 · eISSN 2284-0729 · Verduci Editore · ITALY · Bimonthly · Founded 1997
European Review for Medical and Pharmacological Sciences: impact factor 1.73; fully open access; APC about USD 1,964; review 2–4 weeks (community reports); community-reported acceptance: easy; 1,118 articles a year; indexed in Scopus; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
European Review for Medical and Pharmacological Sciences is published by Verduci Editore. By OpenAlex counts of its recent articles, its largest topics are Hepatitis C virus research, Epilepsy research and treatment and Hepatitis B Virus Studies, together about 18.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
acts as an information exchange tool for several aspects of medical and pharmacological sciences. It publishes reviews, original articles, and results from original research. The purposes of the Journal are to encourage interdisciplinary discussions and to contribute to the advancement of medicine.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editorial board by country: 1 in mainland China (about 2%); most named Italy 40, Greece 4, United States 3, Brazil 2, Mainland China 1 (58 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Hepatitis C virus researchMedicine7.9%
- Epilepsy research and treatmentMedicine5.3%
- Hepatitis B Virus StudiesMedicine5.3%
- Antibiotics Pharmacokinetics and EfficacyMedicine5.3%
- Mycobacterium research and diagnosisMedicine5.3%
- Electroconvulsive Therapy StudiesMedicine5.3%
- Electrolyte and hormonal disordersMedicine5.3%
- Skin Diseases and DiabetesMedicine5.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
ScopusLetPub
Early warning / risk: Removed from SCIE for editorial reasons on 22 May 2024. CAS Early Warning Journal List: listed in the 2020 edition (high risk); not listed in the other 5 editions.LetPub
Indexing the journal's website claims
MEDLINEPubMedEmbasePublisher website
Other: EBSCO, Excerpta Medica
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.73LetPub ·
- CiteScore 2026-06
- 5.3LetPub ·
- SJR 2026-06
- 0.58LetPub ·
- SNIP 2026-06
- 0.61LetPub ·
- h-index
- 48LetPub ·
- h-index
- 3OpenAlex ·
- i10-index
- 0OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 1,118LetPub ·
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 2–4 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | EUR 1,800 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted3
- original articlesIt publishes reviews, original articles, and results from original research.Length not stated
- results from original researchIt publishes reviews, original articles, and results from original research.Length not stated
- reviewsIt publishes reviews, original articles, and results from original research.Length not stated
Policy excerpts from the journal's websiteData availability, Peer review, Plagiarism
- Data availability
Digital preservation via CLOCKSS. Model summary
Our Journal is committed to the permanent availability and preservation of scholarly research and to ensure accessibility by upgrading digital file formats to comply with new technology standards such as CLOCKSS.
Source ↗Publisher website ·- Peer review
Image integrity screening with accredited software. Model summary
The journal employs accredited software to identify integrity concerns in figures.
Source ↗Publisher website ·- Plagiarism
Plagiarism screening with iThenticate and Grammarly. Model summary
Our Journal uses certified plagiarism checker software (iThenticate® and Grammarly®) to verify the authenticity of articles and detect duplications from each article content online against billions of web pages.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Verduci Editore
- Country or region
- ITALY
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1997
- ISSN
- 1128-3602
- Electronic ISSN
- 2284-0729
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about European Review for Medical and Pharmacological Sciences
What is the impact factor of European Review for Medical and Pharmacological Sciences?
The latest impact factor listed by LetPub is 1.73; CiteScore 5.3, h-index 3.
How long does peer review take at European Review for Medical and Pharmacological Sciences?
Authors report an average review time of 2–4 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of European Review for Medical and Pharmacological Sciences based?
Of the 58 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are Italy (40), Greece (4) and United States (3). Counted from the institutions listed on the board page; for reference only.
Which databases index European Review for Medical and Pharmacological Sciences?
According to LetPub and DOAJ records, European Review for Medical and Pharmacological Sciences is indexed in Scopus. The journal's website also lists MEDLINE, PubMed and Embase; that list has not been checked against each database.
Is European Review for Medical and Pharmacological Sciences open access, and what is the APC?
European Review for Medical and Pharmacological Sciences is a fully open-access journal. APC about USD 1,964.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .